188 related articles for article (PubMed ID: 9252165)
21. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China.
Cao Z; Bai X; Guo X; Jin Y; Qian G; Tu H
Arch Virol; 2008; 153(10):1807-12. PubMed ID: 18726170
[TBL] [Abstract][Full Text] [Related]
23. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
Kim HJ; Yoo BC
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
[TBL] [Abstract][Full Text] [Related]
24. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
25. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
26. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
[TBL] [Abstract][Full Text] [Related]
27. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
[TBL] [Abstract][Full Text] [Related]
28. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
[TBL] [Abstract][Full Text] [Related]
29. A Quasi species of the pre-S/S gene and mutations of enhancer II/core promoter/pre-C in mothers and their children infected with hepatitis B virus via mother-to-infant transmission.
Xu H; Peng M; Qing Y; Ling N; Lan Y; Liang Z; Cai D; Li Y; Ren H
J Infect Dis; 2006 Jan; 193(1):88-97. PubMed ID: 16323136
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically.
Song BC; Kim SH; Kim H; Ying YH; Kim HJ; Kim YJ; Yoon JH; Lee HS; Cha CY; Kook YH; Kim BJ
J Med Virol; 2005 Jun; 76(2):194-202. PubMed ID: 15834881
[TBL] [Abstract][Full Text] [Related]
32. [Hepatitis B virus mutants--clinical significance].
Blum HE; Moradpour D; vøn Weizsäcker F; Wieland S; Peters T; Rasenack JW
Z Gastroenterol; 1997 May; 35(5):347-55. PubMed ID: 9265394
[TBL] [Abstract][Full Text] [Related]
33. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
34. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
35. Detection by ligase chain reaction of precore mutant of hepatitis B virus.
Minamitani S; Nishiguchi S; Kuroki T; Otani S; Monna T
Hepatology; 1997 Jan; 25(1):216-22. PubMed ID: 8985293
[TBL] [Abstract][Full Text] [Related]
36. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
[TBL] [Abstract][Full Text] [Related]
37. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.
Cho SW; Hahm KB; Kim JH
Hepatology; 2000 Nov; 32(5):1163-9. PubMed ID: 11050070
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
39. [Mutation of hepatitis B virus DNA pre-C region in patients with primary hepatocellular carcinoma in Guangxi].
Fang Z; He B; Zhuang H; Ring L; Harrison TJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):83-5. PubMed ID: 11860905
[TBL] [Abstract][Full Text] [Related]
40. Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands.
Utsumi T; Yano Y; Truong BX; Tanaka Y; Mizokami M; Seo Y; Kasuga M; Kawabata M; Hayashi Y
J Med Virol; 2007 Mar; 79(3):229-35. PubMed ID: 17245721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
